HealthQuill National Institute of Allergy and Infectious Diseases
The National Instituted of Health, US, has started a mid-stage clinical trial to examine the safety and acceptability of a rectal microbicide douche containing the antiretroviral drug tenofovir to prevent HIV infection spread among men.
Drugs Health Pharma

Mid-stage trial of a rectal microbicide for HIV prevention in the US begins 

HQ Team November 3, 2024: The National Instituted of Health, US, has started a mid-stage clinical trial to examine the safety and acceptability.

Read More
Antibodies to target a hard-to-spot region or the “dark side” of the influenza virus were discovered by researchers, and may pave new vaccines and therapies to fight the disease.
Drugs Health Pharma

Antibody discovery may aid new vaccines, therapies to fight influenza

HQ Team March 3, 2024: Antibodies to target a hard-to-spot region or the “dark side” of the influenza virus were discovered by researchers,.

Read More
Human trials to stop radioactive contaminants begin
Drugs Health Medical Pharma

Human trials to stop radioactive contaminants in body begin

HQ Team May 17, 2023: The first trial on humans of an experimental oral drug for removing radioactive contaminants from inside the body.

Read More